Clinical Trials Browser

Phase 1 × dalpiciclib × Clear all

NCT06109207 2024-07-23

Neoadjuvant Camrelizumab With Dalpiciclib for Resectable Head and Neck Squamous Cell Carcinomas

Phase 1 Recruiting

Squamous Cell Carcinoma of Head and Neck

NCT06225921 2024-03-06

Neoadjuvant Adebrelimab With Dalpiciclib for Resectable Esophageal Squamous Cell Carcinomas

Phase 1 Recruiting

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT05586841 2022-10-19

Exploration of Dalpiciclib + Chidamide in HR+/HER2- Advanced Breast Cancer After Failure of CDK4/6 Inhibitor: a Phase Ⅰb Study

Phase 1 Unknown

HR+/HER2- Advanced Breast Cancer